TSO3 Receives 2017 Purchase Orders from Getinge
Backlog for the STERIZONE® VP4 Sterilizer Exceeds $18 Million
QUÉBEC CITY, Dec. 2, 2016 / - TSO3 Inc. (TSX:TOS.TO - News) ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, has received initial purchase orders from Getinge USA, Inc., for fiscal 2017. These orders will increase the rate of production and throughput from the Company's assembly facility in Quebec throughout 2017.
The purchase orders were received in association with the distribution agreement signed with Getinge in November 2015.
"This PO from Getinge provides a degree of operational predictability for 2017 as it enables TSO3 to leverage supply chain improvements achieved in fiscal 2016," said R.M. (Ric) Rumble, TSO3's President and CEO. "We look forward to further collaboration and success as we enter our second year of this strategic partnership. TSO3, together with Getinge continue to collaborate and deploy an increasing number of sterilizers and deliver on our vision – Creating the Improved Standard in Healthcare Sterile Reprocessing™."
- Published: 02 December 2016
- Written by Editor
- Hits: 56